Leslie A. Crews, assistant professor of medicine in the Division of Regenerative Medicine at UC San Diego, was named co-leader of the MCC Hematologic Malignancies Program. Crews will join current co-leader, Thomas Kipps, professor of medicine and Evelyn and Edwin Tasch Chair in Cancer Research.
Researchers at the University of California San Diego and La Jolla Institute of Immunology have discovered a promising treatment approach for pancreatic cancer, one of the deadliest and most treatment-resistant forms of cancer. The approach leverages the body’s natural immune response to cytomegalovirus, a common but typically harmless virus that most people are infected with at some point in their lives.
